Expert Highlights Benefits of Fedratinib in Subgroup of Patients With Myelofibrosis

Press/Media: Press / Media

PeriodJan 19 2020

Media coverage

1

Media coverage

  • TitleExpert Highlights Benefits of Fedratinib in Subgroup of Patients With Myelofibrosis
    Media name/outletTargeted Oncology
    CountryUnited States
    Date1/19/20
    PersonsRuben Mesa